Solventum Corp reported $13.97B in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
Abbott USD 84.18B 182M Sep/2025
Align Technology USD 6.23B 14.46M Sep/2025
Baxter International USD 21.07B 21M Sep/2025
Becton, Dickinson and Co. USD 55.32B 423M Sep/2025
Cencora USD 76.59B 2.63B Sep/2025
Dexcom USD 7.5B 173M Sep/2025
Insulet USD 3.03B 439.9M Sep/2025
Solventum Corp USD 13.97B 1.1B Sep/2025
West Pharmaceutical Services USD 4.11B 153M Sep/2025
Zimmer Biomet Holdings USD 23.49B 622.9M Sep/2025